Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Accounts Payable Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Accounts Payable
CHf2.9m
CAGR 3-Years
-35%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Accounts Payable
$15.6m
CAGR 3-Years
43%
CAGR 5-Years
18%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Accounts Payable
CHf1.4m
CAGR 3-Years
68%
CAGR 5-Years
48%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Accounts Payable
$15.6m
CAGR 3-Years
15%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Accounts Payable
CHf11.5m
CAGR 3-Years
29%
CAGR 5-Years
28%
CAGR 10-Years
24%
Kuros Biosciences AG
SIX:KURN
Accounts Payable
CHf2.8m
CAGR 3-Years
68%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Accounts Payable?
Accounts Payable
2.9m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Accounts Payable amounts to 2.9m CHF.

What is Molecular Partners AG's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-1%

Over the last year, the Accounts Payable growth was 4%. The average annual Accounts Payable growth rates for Molecular Partners AG have been -35% over the past three years , -1% over the past five years .

Back to Top